Sugi Predict

Sugi Predict / Compounds / SCHEMBL20317138

SCHEMBL20317138

SCHEMBL20317138

c1ccc(-c2ccc(-c3ccccc3Nc3cccc(-c4cccc5c4oc4ccccc45)c3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.53
▸ PTGES2 Q9H7Z7 1/20 0.47
▸ EPHX2 P34913 1/20 0.43
▸ GGPS1 O95749 1/20 0.43
▸ AKR1C3 P42330 4/20 0.43
▸ PRKDC P78527 2/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ CDC25B P30305 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ TYK2 P29597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18767403 0.94 ALOX5 (0.52) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL20317141 0.92 SIRT2 (0.42) ALOX5PTGES2EPHX2AKR1C3PRKDC
SCHEMBL16562456 0.92 ALOX5 (0.50) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL20317145 0.91 ALOX5 (0.52) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL20317130 0.91 ALOX5 (0.50) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL16366435 0.90 ALOX5 (0.49) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL27383641 0.90 ALOX5 (0.50) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL15840165 0.90 ALOX5 (0.51) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL29514842 0.90 ALOX5 (0.51) ALOX5PTGES2EPHX2GGPS1AKR1C3
SCHEMBL25747692 0.90 ALOX5 (0.55) ALOX5PTGES2EPHX2GGPS1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840456-B2 Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-11-17 — — US disclosed
US-20180182974-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-06-28 — — US disclosed
US-20180182974-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182974-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 ALOX5 2463/4885PTGES2 3203/4885EPHX2 1210/4885
US-10840456-B2 Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device L1CAM, PIEZO1, LEF1 ALOX5 2463/4885PTGES2 3203/4885EPHX2 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.